Biofrontera AG (ETR:B8FK)
Germany
· Delayed Price · Currency is EUR 2.370
-0.050 (-2.07%)
At close: Jun 18, 2025, 5:30 PM CET
Biofrontera AG Revenue
Biofrontera AG had revenue of 5.77M EUR in the quarter ending March 31, 2025, with 55.35% growth. This brings the company's revenue in the last twelve months to 23.72M, down -21.35% year-over-year. In the year 2024, Biofrontera AG had annual revenue of 21.67M, down -32.81%.
Revenue (ttm)
23.72M
Revenue Growth
-21.35%
P/S Ratio
0.61
Revenue / Employee
272.66K
Employees
88
Market Cap
14.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.67M | -10.58M | -32.81% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | 30.35M | -919.00K | -2.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.14B |
| Merck KGaA | 21.32B |
| Bayer Aktiengesellschaft | 46.58B |
| Fresenius SE & Co. KGaA | 22.13B |
| Fresenius Medical Care AG | 19.49B |
| Sartorius Aktiengesellschaft | 3.44B |
| Carl Zeiss Meditec AG | 2.17B |
| Fielmann Group AG | 2.33B |